Exchange: NASDAQ·Updated 05:03 PM EDT

KLRAKailera Therapeutics Inc.

$22.11
$0.48
(2.16%)
Today
Closed $21.76
$0.35
(1.61%)
After Hours
EarningsAug 7
Mkt Cap$2.88B
Vol812,824.00
News
all
press releases
News Placeholder
Why Is Kailera Therapeutics Stock Falling Tuesday?
Kailera Therapeutics oral GLP-1 meets Phase 3 targets for obesity and diabetes. KLRA stock falls 9% on reported GI side effects.read more...
Benzinga
News Placeholder
Is Kailera Therapeutics a Buy After Its Sizzling IPO?
Is Kailera Therapeutics a Buy After Its Sizzling IPO...
Yahoo! Finance: News
News Placeholder
A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Million
Key Points500,000 shares were acquired for a transaction value of $8.00 million on April 20, 2026...
Nasdaq News: Markets
News Placeholder
Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth
Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth PR Newswire SHANGHAI, April 22, 2026 SHANGHAI...
PR Newswire
<
...
1
>

Advertisement|Remove ads.